Biofourmis Care

Personalize care virtually anywhere, with customized solutions to help clinicians provide care to patients with acute, post-acute, and chronic conditions.

Advancing Virtual Care with World-renowned Hospitals

Our turnkey, hospital at home solution, co-developed with Brigham and Women’s Hospital, delivers high-quality, safe, and affordable acute care, while significantly reducing costs, readmissions, and healthcare use compared to traditional hospital care.¹

1 Levine, David M., et al. “Hospital-level care at home for acutely ill adults: a randomized controlled trial.” Annals of Internal Medicine 172.2 (2020): 77-85.

Optimizing Outcomes with Artificial Intelligence and Machine Learning

Biofourmis Care provides a holistic, customizable solution to deliver virtual care to patients with acute, post-acute, and chronic medical conditions. This approach delivers the right care to the right patient at the right time, in the place where they are most comfortable – their own home. Biofourmis Care enables health systems to:

Establish a personalized patient baseline and receive notifications as patient conditions change, as the patient is monitored continuously and in real-time
Tailor care based on context-rich patient insights, and intervene early when needed, reducing readmissions and associated costs
Enhance workflow efficiencies and care team capacity with the ability to simultaneously deliver care in a healthcare facility and to virtual beds
Realize more rapid, personalized treatment and communication for more efficient patient management across the care continuum

The Biofourmis Care Technology Ecosystem

Biovitals Index

Our FDA-cleared Biovitals Index utilizes artificial intelligence and machine learning to interpret and analyze physiological signals, delivering personalized patient insight. Medical-grade wearables allow for continuous, real-time monitoring and patient-specific notifications enable caregivers to deliver exceptional care independent of a patient’s physical location.

Central Monitoring Dashboard

A secure dashboard enables healthcare providers to monitor patients from a central hub. When patient deterioration is detected, actionable notifications enable caregivers to deliver real-time clinical interventions. With EHR-compatibility, our solution streamlines medical workflows and operations, assisting clinicians as they provide care for patients recovering in the comfort of their own homes.

Patient-centric Platform

The intuitive, easy-to-use patient application enhances patient engagement and adherence through the delivery of a personalized treatment plan and communication portal. Customized plans include patient tasks, reminders, and resources to support each patient on his or her path to recovery and independence and the communications portal provides a direct connection to a patient’s care team.

Download our free eBook to learn how to initiate a Hospital@Home program.

Healthcare delivery outside the hospital is fast-paced, and leaders in the healthcare industry must work toward innovating virtual healthcare solutions for better clinical outcomes while reducing the cost and burden of care. Brigham & Women’s, an active user of the Biofourmis Hospital@Home program, reduced hospital admissions by 70% and saw a 40% cost reduction when they harnessed the power of personalized, predictive care. Download this reference guide to initiate your virtual care program to realize improved outcomes and efficiencies.

Trusted by Leading Health Systems, Providers, Pharmaceutical Companies, and More

What Our Customers Are Saying

“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital therapeutics, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology.”

"The Everion^® biosensor has become part of my daily habit. I wear it and forget about it and I know a care team is always there to make sure I am safe."

"The goal of this program is to leverage Biovitals^® to remotely monitor patients and identify COVID-19 related physiological biomarkers that indicate deterioration in patients."